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A B S T R A C T
Parry-Romberg syndrome (PRS) is a poorly understood degenerative disease characterized by atrophy af-
fecting one side of the face. In this report, we describe a patient with PRS associated with exposure
keratopathy and corneal ulceration as a result of lagophthalmos. The clinical ﬁndings and staged com-
posite reconstruction are described.
© 2015 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Parry-Romberg syndrome (PRS), also known as “progressive facial
hemiatrophy,” is a rare, acquired disorder characterized by pro-
gressive but self-limiting unilateral wasting of facial skin, subcu-
taneous fat, muscle, and occasionally bone [1–3]. It can be associated
with various ophthalmic and neurologic complications [4]. A dis-
tinct border may exist between unaffected and atrophied tissue, re-
sulting in a vertical “line” seen most prominently on the forehead
(25% of cases) referred to as linear scleroderma “en coupe de sabre”
(French termmeaning “cut of the sword”) [5]. The incidence of PRS
has been estimated at 1:250,000-700,000 [4].
Caleb Parry, a British physician, ﬁrst described the condition in
1825 in a collection of personal medical writings. The condition was
further characterized by German neurologistMoritz Romberg in 1846
[6,7]. Despite PRS having been recognized as a distinct condition
for more than 150 years, the etiology remains elusive [8,9]. The
leading theory is that PRS is an autoimmune disorder [10], but other
factors may include trauma, viral infection, endocrine distur-
bances, and genetic anomalies [11]. PRS usually has an insidious
onset during the ﬁrst or second decade of life [12,13]. Then, 2-10
years after onset, a period of rapid progression occurs before the
condition becomes quiescent [2]. PRS is more common in females
and it is usually observed on the left side of the face [11]. Associ-
ated neurologic ﬁndings include migraine headaches, seizures, and
trigeminal neuralgia [14].
Ophthalmologic complications include enophthalmos due to
atrophy of orbital fat and eyelid ptosis [15]. Ocular manifestations
described include coloboma, vitreous hemorrhage, diffuse pigmen-
tary changes in the retina, and chorioretinal atrophy [16]. Corneal
ulcerations secondary to lagophthalmus and exposure keratopathy
have not been commonly reported.
No consensus exists on the optimal treatment of PRS [5]. Once
PRS is quiescent, autogenous (eg, fat, bone, cartilage) grafts or
alloplastic (eg, silicone or porous polyethylene) implants have been
used to improve the atrophic facial appearance [17,18]. No consen-
sus exists for restoration of the multifactorial enophthalmos and
lagophthalmos [19].
In this report, we describe a case of PRS with exposure
keratopathy and severe corneal ulceration as a result of lagoph-
thalmus and altered position of the globe. The patient was suc-
cessfully reconstructed using a free serratusmyofascial microvascular
ﬂap, iliac crest, and cranial bone grafts.
2. Presentation of case
A 38-year-old Iranian woman presented to the Medical Univer-
sity of South Carolina with worsening left facial disﬁgurement,
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left-sided eye pain irritation, and foreign body sensation with de-
creased visual acuity. The deformity had its onset 18 years prior to
presentation, but had progressively worsened over the previous 6
years. The patient began developing symptoms of dryness and ul-
ceration in her left eye about 12months prior to presentation. Sixteen
years prior to presentation, she had placement of a silicone implant
in Iran to augment the left forehead. There was no previous facial
trauma or toxic exposure. Her past medical history was notable for
depression and a hemorrhagic stroke 15 years prior to presenta-
tion. The patient had no family history of facial deformity.
Physical examination revealed atrophy of the left upper and
middle facial thirds resulting in enophthalmos (4-5 mm by Luedde
exophthalmometer). There was a depression of the forehead ex-
tending from the left temporal region to themidline, with a palpable
ridge at the medial extent (Figure 1). There was a hyperpig-
mented area in the paramedian forehead. The patient had severe
lagophthalmos with chemosis, and inﬁltration of the corneal stroma.
There was a 4-mm corneal ulcer from the temporal lower quad-
rant to the center. The sulci of the left upper and lower eyelids
were markedly hallowed and retracted. The upper eyelid was retro-
placed behind the superior orbital rim. A tarsorrhaphy suture from
the lateral lower eyelid to the midline of the upper lid was present.
The nasal bridge was depressed on the left, with the nasal tip
deviated to the left; however, there was minimal deformity of the
maxilla below the inferior orbital rim.
Neurologic examination revealed no sensory or facial nerve deﬁcit
and active left levator palpebrae superioris function. There was left
masseter and temporalis atrophy and weakness. The tongue was
symmetric and protruded in the midline. The patient had full power
in all extremities, with no atrophy or fasciculation. The remaining
neurologic examination was notable for 3 + deep tendon reﬂexes in
the right upper and lower extremities.
Computed tomography conﬁrmed atrophy of the left periorbital
soft tissue extending from the subcutaneous tissue to the extra and
intraconal soft tissue. T1-weighted axialmagnetic resonance imaging
of the face showed striking paucity of fat on the left face, as well as
atrophy of the periorbital soft tissue around the left orbit (Figure 2).
The left frontal bone was also signiﬁcantly thinned. Magnetic reso-
nance imaging of the brain revealed leptomeningeal enhancement
in the right frontotemporal region without evidence of ischemia.
A diagnosis of PRS associated with exposure keratopathy was
made. The patient elected to undergo reconstructive surgery using
free tissue transfer for restoration of intraorbital soft tissue volume,




Figure 1. Preoperative clinical photograph: (A) close-up view showing the tarsorrhaphy suture and “en coupe de sabre” deformity on the forehead, (B) frontal view showing
facial asymmetry, (C) 45° view showing severe enophthalmus of the left eye, and (D) right lateral view showing the normal position of the right globe.
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The silicone implant over the frontal bone was removed and re-
placed with a corticocancellous iliac crest graft. A 4 × 1.5 cm piece
of cranial bone graft was used to augment the left supraorbital rim.
To restore intraorbital volume, myofascial ﬂaps from the superior
surface of the serratus anterior muscle and the undersurface of the
latissimus dorsi muscle were harvested using the subscapular artery
and vein as a common vascular pedicle. The larger serratus ante-
rior myofascial ﬂap was inset to the subperiosteal space of the su-
perior orbit, and the smaller latissimus dorsi myofascial ﬂap was
then placed subperiosteally along the orbital ﬂoor. The pedicle was
then tunneled in the subcutaneous plane from the lateral orbital
rim and anastomosed to the superﬁcial temporal artery and vein.
The patient’s globe position and projection improved with reso-
lution of her ocular symptoms and injuries (Figure 3). At 8-year
follow-up, the patient had no residual eye pain, irritation, or foreign
body sensation. The augmented frontal bone and supraorbital rim
had minimal resorption (Figure 4). There was no sign of corneal ul-
ceration or keratopathy. There was a 3-mm stromal scar on the nasal
side of the left cornea consistent with a healed ulcer.
3. Discussion
PRS is an uncommon and poorly understood disorder of unknown
etiology [20]. The progressive composite tissue atrophy that occurs
has been proposed to be a result of genetic susceptibility, cranial
vascular malformations, immune-mediated processes, trauma, and
disturbance of fat [21–23]. As in the presented case, in addition to
aesthetic deformity, this disease has been associated with several
functional and severe psychological problems [18].
In this case of PRS, there was associated corneal ulceration and
exposure keratopathy, which improved after restoration of globe
support using a complex myofascial microvascular ﬂap that pre-
vented permanent loss of visual acuity without the need for further
tarsorrhaphy. Locoregional ﬂaps (ie, temporalis muscle) were not
possible because of atrophy as part of the disease.
Ocular changes are present in 10% to 35% of PRS cases, with
enophthalmos being most frequent. Corneal damage has been re-
ported in only a few case reports and has included irregular round
deposits, endothelial failure, and band keratopathy [24–26]. In
this case, severe corneal ulceration and exposure keratopathy
occurred as a result of lid retraction and lagophthalmus due to
atrophy of the supporting orbital fat and bony orbit. It is most
likely that atrophy of the orbital fat caused the upper eyelid skin
to retract into the deep superior sulcus, decreasing the eyelid cord
length and thus functionally diminishing the anterior lamella. This
Figure 2. A T1-weighted magnetic resonance imaging (axial view) showing the
paucity of fat around the left orbit (arrow) and enophthalmos.
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Figure 3. Clinical photographs 3 months postoperative: (A) frontal view showing the improved symmetry of the face, and (B) left lateral view showing improved projec-
tion and position of the left globe.
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resulted in the upper eyelid being 5 mm posterior to the superior
orbital rim.
PRS is a self-limiting condition with no cure. Affected patients
require multidisciplinary management by reconstructive sur-
geons, dentists, phonoaudiologists, and psychiatrists. No treat-
ment options have been shown to affect the natural history of the
disease [11]. Operative management usually focuses on restoring
the atrophied adipose tissue. Autogenous fat grafts, cartilage grafts,
silicone injections, bovine collagen, and inorganic implants are al-
ternatives to free tissue transfer for aesthetic correction of atrophy
[27]. Osseous atrophy can be corrected with autogenous bone (ie,
iliac crest or cranial bone), allograft, or alloplast. The iliac crest and
cranial bone used for the frontal bone and orbital rims in this case
remained stable at 8 years in this case.
4. Conclusion
PRS is a rare condition of slowly progressive unilateral cranio-
facial atrophy of unknown etiology. End-stage correction is done
by restoration of lost tissue volume. The patient in this report had
progressive ocular damage that was successfully treated with res-
toration of intraorbital tissue and supporting orbital rims to improve
globe support and eyelid function.
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Figure 4. Clinical photographs 8 years postoperative showing relative stability of the osseous augmentation, with some additional atrophy of the graft on the (A) frontal
view and (B) left lateral view.
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